ARG
AMPE

Advisory Resource Group’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Advisory Resource Group’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-500
Closed -$2.33K – 166
2023
Q2 		$2.33K Hold
500
– – ﹤0.01% 150
2023
Q1 		$2.33K Hold
500
– – ﹤0.01% 147
2022
Q4 		$2.25K Buy
+500
New +$3.23K ﹤0.01% 145

Other funds holding AMPE

CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
GIA
GHP Investment Advisors Denver, Colorado $2.72B AUM 27.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
JWM
Janiczek Wealth Management Denver, Colorado $477M AUM 15.17% 1-Year Est. Return

Advisory Resource Group's AMPE Position: Q3 2023 in Review

Advisory Resource Group sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q3 2023, closing a stake of 500 shares — an estimated $2.33K sold.

Advisory Resource Group first reported a position in AMPE in Q4 2022 and held it in 3 quarters. The position peaked at $2.33K in Q2 2023. 26 funds tracked by Wall St. Rank hold AMPE as of Q3 2023.

  • Advisory Resource Group reported no remaining Ampio Pharmaceuticals Inc. position as of Q3 2023 after selling out during the quarter.
  • Advisory Resource Group sold 500 Ampio Pharmaceuticals Inc. shares in Q3 2023, an estimated $2.33K.
  • Advisory Resource Group first reported a position in Ampio Pharmaceuticals Inc. in Q4 2022 and held it in 3 quarters.
  • Advisory Resource Group's Ampio Pharmaceuticals Inc. position peaked at $2.33K in Q2 2023.
  • 26 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q3 2023.

Based on Advisory Resource Group's 13F filing for Q3 2023, filed 5 Dec 2023.